198 related articles for article (PubMed ID: 27043049)
1. Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening.
Sarpel D; Baichoo E; Dieterich DT
Expert Rev Anti Infect Ther; 2016; 14(5):511-21. PubMed ID: 27043049
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.
Suijkerbuijk AWM; van Hoek AJ; Koopsen J; de Man RA; Mangen MJ; de Melker HE; Polder JJ; de Wit GA; Veldhuijzen IK
PLoS One; 2018; 13(11):e0207037. PubMed ID: 30408079
[TBL] [Abstract][Full Text] [Related]
3. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States.
McEwan P; Ward T; Yuan Y; Kim R; L'italien G
Hepatology; 2013 Jul; 58(1):54-64. PubMed ID: 23389841
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.
Heidrich B; Cetindere A; Beyaz M; Stahmeyer JT; Basaran MM; Braynis B; Raupach R; Bremer B; Manns MP; Wedemeyer H; Bastürk M
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1090-7. PubMed ID: 25076065
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of screening for chronic hepatitis C infection in the United States.
Eckman MH; Talal AH; Gordon SC; Schiff E; Sherman KE
Clin Infect Dis; 2013 May; 56(10):1382-93. PubMed ID: 23392392
[TBL] [Abstract][Full Text] [Related]
6. Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness.
Wong JB
Acta Gastroenterol Belg; 1998; 61(2):238-42. PubMed ID: 9658620
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of screening immigrants for hepatitis B.
Wong WW; Woo G; Jenny Heathcote E; Krahn M
Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
[TBL] [Abstract][Full Text] [Related]
8. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.
Perumalswami PV; Factor SH; Kapelusznik L; Friedman SL; Pan CQ; Chang C; Di Clemente F; Dieterich DT
J Hepatol; 2013 May; 58(5):890-7. PubMed ID: 23333446
[TBL] [Abstract][Full Text] [Related]
10. Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey.
Papatheodoridis G; Sypsa V; Kantzanou M; Nikolakopoulos I; Hatzakis A
J Viral Hepat; 2015 Apr; 22(4):409-15. PubMed ID: 25209157
[TBL] [Abstract][Full Text] [Related]
11. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
Larcos G; Sorokopud H; Berry G; Farrell GC
AJR Am J Roentgenol; 1998 Aug; 171(2):433-5. PubMed ID: 9694470
[TBL] [Abstract][Full Text] [Related]
12. Economics of chronic hepatitis B and hepatitis C.
Rajendra A; Wong JB
J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
[TBL] [Abstract][Full Text] [Related]
13. Problems and prevention of viral hepatitis in Thailand.
Poovorawan Y; Chongsrisawat V; Tangkijvanich P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S18-25. PubMed ID: 11529332
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium].
Adler M; Bourgeois N
Rev Med Brux; 2001 Jun; 22(3):141-51. PubMed ID: 11488081
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.
Roberts H; Kruszon-Moran D; Ly KN; Hughes E; Iqbal K; Jiles RB; Holmberg SD
Hepatology; 2016 Feb; 63(2):388-97. PubMed ID: 26251317
[TBL] [Abstract][Full Text] [Related]
16. Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
Barth C; Neusser S; Biermann J; Wasem J; Berg T; Wiegand J; Wolffram I; Petroff D; Aidelsburger P; Grünbauer A; Neumann A
Scand J Gastroenterol; 2018 Jan; 53(1):76-82. PubMed ID: 29065740
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
Ward JW
Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
Day FL; Karnon J; Rischin D
J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
[TBL] [Abstract][Full Text] [Related]
19. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
Weinbaum CM; Williams I; Mast EE; Wang SA; Finelli L; Wasley A; Neitzel SM; Ward JW;
MMWR Recomm Rep; 2008 Sep; 57(RR-8):1-20. PubMed ID: 18802412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
